Geneva Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $1.64M | Sell |
19,937
-305
| -2% | -$25.1K | 0.03% | 266 |
|
|
2017
Q1 | $1.7M | Sell |
20,242
-154
| -0.8% | -$13K | 0.03% | 244 |
|
|
2016
Q4 | $1.5M | Sell |
20,396
-770
| -4% | -$56.6K | 0.03% | 260 |
|
|
2016
Q3 | $1.7M | Buy |
21,166
+1,504
| +8% | +$121K | 0.03% | 225 |
|
|
2016
Q2 | $1.55M | Buy |
19,662
+177
| +0.9% | +$13.9K | 0.03% | 232 |
|
|
2016
Q1 | $1.4M | Sell |
19,485
-1,397
| -7% | -$101K | 0.03% | 240 |
|
|
2015
Q4 | $1.76M | Sell |
20,882
-48
| -0.2% | -$4.05K | 0.03% | 214 |
|
|
2015
Q3 | $1.75M | Buy |
20,930
+1,170
| +6% | +$97.9K | 0.04% | 220 |
|
|
2015
Q2 | $1.65M | Sell |
19,760
-639
| -3% | -$53.4K | 0.03% | 231 |
|
|
2015
Q1 | $1.48M | Buy |
20,399
+1,655
| +9% | +$120K | 0.03% | 240 |
|
|
2014
Q4 | $1.29M | Buy |
18,744
+790
| +4% | +$54.5K | 0.02% | 254 |
|
|
2014
Q3 | $1.16M | Buy |
17,954
+63
| +0.4% | +$4.08K | 0.02% | 281 |
|
|
2014
Q2 | $1.11M | Buy |
17,891
+254
| +1% | +$15.8K | 0.02% | 295 |
|
|
2014
Q1 | $1.04M | Buy |
17,637
+608
| +4% | +$35.8K | 0.02% | 289 |
|
|
2013
Q4 | $868K | Sell |
17,029
-3,298
| -16% | -$168K | 0.02% | 270 |
|
|
2013
Q3 | $1.02M | Sell |
20,327
-253
| -1% | -$12.7K | 0.02% | 246 |
|
|
2013
Q2 | $1.01M | Buy |
+20,580
| New | +$1.01M | 0.02% | 215 |
|